Opus Genetics is trading 5.35% higher at $5.22, compared with its September 29 close of $4.96; no clear company-specific catalyst has been identified.
- The Nasdaq Composite is up 1.00%, a possible supportive backdrop, though no direct connection has been established.
- Opus Genetics has an Euretina Innovation Spotlight presentation scheduled for September 30, but no evidence ties it to the move.
- No trading-volume details were identified.